NASDAQ:HIND Vyome Q2 2026 Earnings Report $2.01 +0.06 (+3.08%) Closing price 09/23/2026 04:00 PM EasternExtended Trading$1.89 -0.12 (-5.97%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Vyome EPS ResultsActual EPS-$0.10Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AVyome Revenue ResultsActual Revenue$0.27 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AVyome Announcement DetailsQuarterQ2 2026Date8/12/2026TimeAfter Market ClosesConference Call DateWednesday, August 12, 2026Conference Call Time7:00AM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Vyome Earnings HeadlinesAverage price target for Vyome Holdings decreased by 23.19% to $9.01September 17, 2026 | msn.comVyome Holdings, Inc. (NASDAQ:HIND) Receives Consensus Rating of "Moderate Buy" from BrokeragesSeptember 15, 2026 | americanbankingnews.comNASA's ISS Replacement Could Go to This Tiny Space FirmNASA has commissioned SpaceX to decommission the $150 billion International Space Station, but the contract to build its replacement is reportedly headed to a tiny firm a fraction of SpaceX's size, one NASA has quietly funded for five years. History shows these NASA announcements can move fast: Intuitive Machines jumped 66% in a day, Momentus soared 155%, and Sidus Space climbed 180% after landing subcontractor roles. | Behind the Markets (Ad)Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial OfficerSeptember 14, 2026 | finance.yahoo.comVyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial OfficerSeptember 14, 2026 | businesswire.comChardan Capital initiates coverage of Vyome Holdings (HIND) with buy ratingSeptember 4, 2026 | msn.comSee More Vyome Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Vyome? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vyome and other key companies, straight to your email. Email Address About VyomeVyome (NASDAQ:HIND) is a biotechnology company focused on developing therapies for dermatological conditions. The company’s research programs target inflammatory and infectious skin diseases, including acne and other conditions associated with imbalanced skin microbiomes. Vyome has developed topical drug candidates and proprietary approaches intended to selectively address disease-causing bacteria while preserving beneficial microorganisms on the skin. Its pipeline has included investigational treatments for acne and other dermatology indications, although product candidates remain subject to clinical development and regulatory review. The company’s operations are centered on the development of prescription dermatology medicines for potential commercialization in the United States and other international markets. Vyome’s programs are in development, and the availability of approved products may vary by jurisdiction.View Vyome ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Energy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock?Thor Industries Is Boring—And That May Be Its Biggest AdvantageAutoZone Shifts Gears, On Track to Reverse Course and Price RecoveryMeta’s Muse Highlights Arm’s Growing Role in AI InfrastructureOld Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
